Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Apollon Formularies PLC on Tuesday said it has agreed a 28-day extension to complete final due diligence in order to conclude its sale to Global Hemp Group Inc.
The London-based medical cannabis pharmaceutical firm expects the asset sale to take place by April 28, subject to shareholder approval at Apollon’s general meeting on April 11.
The agreed extension will allow for the final inspection of Apollon‘